Pål Aukrust to Double-Blind Method
This is a "connection" page, showing publications Pål Aukrust has written about Double-Blind Method.
Connection Strength
0.125
-
Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease: results of a double-blind placebo-controlled study. J Thromb Haemost. 2006 Oct; 4(10):2140-7.
Score: 0.035
-
[Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin]. Tidsskr Nor Laegeforen. 2001 Jun 20; 121(16):1902-7.
Score: 0.025
-
Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction. Int J Cardiol. 2019 Jan 01; 274:348-350.
Score: 0.020
-
Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study. Eur J Heart Fail. 2018 02; 20(2):268-277.
Score: 0.019
-
Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction. Heart. 2017 10; 103(19):1521-1527.
Score: 0.019
-
Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients. Eur Heart J. 2001 Mar; 22(5):428-36.
Score: 0.006